Sight Sciences

SGHT68

Penny Stock

$3.98arrow_drop_down5.91%-$0.25

Penny Stock

SGHT68

$3.98

arrow_drop_down5.91%-$0.25

Penny Stock

Performance History

Key Stats
Open	$4.48
Prev. Close	$4.59
EPS	-1.06
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$230.91M
PE Ratio	-

	LOW	HIGH
Day Range	4.20	4.59
52 Week Range	1.04	8.45

Ratios







EPS	-1.06

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Sight Sciences (SGHT)

Sight Sciences, Inc. (SGHT) is a company that specializes in developing and commercializing medical devices for opthalmic surgery and treatment. The company's flagship product, the OMNI Surgical System, is a minimally invasive device used in glaucoma surgery. It allows surgeons to target and treat the root causes of glaucoma, which is a leading cause of blindness worldwide. The OMNI Surgical System offers a comprehensive approach to glaucoma treatment, providing both microcatheter-based transluminal viscoelastic delivery and transscleral cyclophotocoagulation. This combination of procedures allows for effective and sustained reduction of intraocular pressure, which is crucial for managing glaucoma.

In addition to the OMNI Surgical System, Sight Sciences also offers the TRAB360, a device used for trabeculotomy, which is another procedure for glaucoma treatment. The TRAB360 provides a minimally invasive approach to accessing the trabecular meshwork, the primary drainage pathway for fluid in the eye. This device is designed to enhance fluid outflow and lower intraocular pressure, providing relief for glaucoma patients.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Paul Badawi
Headquarters: Menlo Park
Employees: 250
Exchange: NASDAQ

Keep an eye on Sight Sciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Sight Sciences's (SGHT) price per share?

The current price per share for Sight Sciences (SGHT) is $3.98. The stock has seen a price change of -$0.25 recently, indicating a -5.91% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Sight Sciences (SGHT)?

For Sight Sciences (SGHT), the 52-week high is $8.45, which is 112.31% from the current price. The 52-week low is $1.04, the current price is 282.69% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Sight Sciences (SGHT) a growth stock?

Sight Sciences (SGHT) has shown an average price growth of -3.13% over the past three years. It has received a score of 45 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Sight Sciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Sight Sciences (SGHT) stock price performance year to date (YTD)?

As of the latest data, Sight Sciences (SGHT) has a year-to-date price change of -21.96%. Over the past month, the stock has experienced a price change of -35.6%. Over the last three months, the change has been -31.26%. Over the past six months, the figure is -26.57%.

help

Is Sight Sciences (SGHT) a profitable company?

Sight Sciences (SGHT) has a net income of -$55.55M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 85.34% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -55.71% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $81.06M, with a revenue growth rate of 13.63%, providing insight into the company's sales performance and growth. The gross profit is $69.18M. Operating income is noted at -$57.27M. Furthermore, the EBITDA is -$49.02M.

help

What is the market capitalization of Sight Sciences (SGHT)?

Sight Sciences (SGHT) has a market capitalization of $206.26M. The average daily trading volume is 4.03, indicating the stock's liquidity and investor engagement.

News

Sight Sciences to Report Second Quarter Financial Results on August 1, 2024 - GlobeNewswire

Sight Sciences CFO Alison Bauerlein sells over $65k in company stock By Investing.com - Investing.com

ENVIRONMENTAL, SOCIAL, AND GOVERNANCE CRITERIA

Jun 10, 2024

Sight Sciences Announces the Release of its First Sustainability Report

PRODUCT / SERVICES ANNOUNCEMENT

CLINICAL STUDY

May 28, 2024

Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis

COMPANY ANNOUNCEMENT

May 28, 2024

Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma

May 2, 2024

Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

About Sight Sciences (SGHT)

Keep an eye on Sight Sciences

Frequently Asked Questions

What is Sight Sciences's (SGHT) price per share?

What is the 52-week high and low for Sight Sciences (SGHT)?

Is Sight Sciences (SGHT) a growth stock?

What is Sight Sciences (SGHT) stock price performance year to date (YTD)?

Is Sight Sciences (SGHT) a profitable company?

What is the market capitalization of Sight Sciences (SGHT)?

News

Sign up for our newsletter

Take Your Investments to a Whole New Level